Bruker (BRKR) Reports Q3 Adj-EPS of $0.10, Beats by 3c
More News related to BRKR
- AREVA T&D and Bruker Energy & Supercon Technologies (BEST) Announce Successful First Test Results for a 13 MVA Shielded, Inductive Superconducting Fault Current Limiter (SFCL)
- Bruker Appoints Bernd Gewiese and Werner Maas as Co-Presidents of its Bruker BioSpin Division
- Bruker Corporation to Present at the Lazard Capital Markets 6th Annual Healthcare Conference
- Bruker Corp. (BRKR) Appoints Knight to COO and Monahan to CFO
- Bruker Corporation Appoints William J. Knight to Chief Operating Officer and Brian P. Monahan to Chief Financial Officer
More News related to Earnings
- Hydrogenics Resumes Trading Under NASDAQ Symbol "HYGS"
- Varian Medical (VAR) to Highlight its New Range of Detectors at Annual RSNA Meeting in Chicago
- Manulife (MFC) Confirms No Exposure to Dubai World
- Activision's (ATVI) Call of Duty Amasses $3 Billion in Global Sales
- Seiko Epson to Transfer Sales Function of Small and Medium-Sized TFT LCD Business to Sony (SNE)
Bruker Corporation (NASDAQ: BRKR) reports Q3 EPS of $0.10, ex-items, 3 cents better than the analyst estimate of $0.07. Revenue for the quarter was $265.1 million, which compares to the estimate of $239.96 million.
Related Categories
EarningsStocks Mentioned
-0.38Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
